Cullinan Therapeutics Appoints Fenton As CFO
(RTTNews) - Monday, Cullinan Therapeutics, Inc. (CGEM) announced the appointment of Mary Kay Fenton as Chief Financial Officer, effective April 29.
With thirty years of financial and operational expertise in the biotechnology sector, Fenton has worked in various companies focusing on different disease areas, such as immunology.
Before joining Cullinan Therapeutics, she held roles as Interim Chief Executive Officer and Chief Financial Officer at Talaris Therapeutics, Inc.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.